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THE IDEATEL CONSORTIUM
OBJECTIVE—The Informatics for Diabetes Education and Telemedicine (IDEATel) project
randomized ethnically diverse underserved older adults with diabetes to a telemedicine inter-
vention or usual care. Intervention participants had lower A1C levels over 5 years. New analyses
were performed to help better understand this difference.
RESEARCH DESIGN AND METHODS—IDEATel randomized Medicare beneﬁciaries
with diabetes (n = 1,665) to receive home video visits with a diabetes educator and upload
glucose levels every 4–6 weeks or usual care (2000–2007). Annual measurements included
BMI, A1C (primary outcome), and completion of questionnaires. Mixed-model analyses were
performed using random effects to adjust for clustering within primary care physicians.
RESULTS—At baseline, A1C levels (mean 6 SD) were 7.02 6 1.25% in non-Hispanic whites
(n = 821), 7.58 6 1.78% in non-Hispanic blacks (n = 248), and 7.79 6 1.68% in Hispanics (n =
585). Over time, lower A1C levels were associated with more glucose uploads (P = 0.02) and
female sex (P = 0.002). Blacks, Hispanics, and insulin-users had higher A1C levels than non-
Hispanicwhites(P,0.0001).BMIwasnotassociatedwithA1Clevels.BlacksandHispanicshad
signiﬁcantly fewer uploads than non-Hispanic whites over time. Hispanics had the highest
baseline A1C levels and showed the greatest improvement in the intervention, but, unlike
non-Hispanic whites, Hispanics did not achieve A1C levels ,7.0% at 5 years.
CONCLUSIONS—Racial/ethnic disparities were observed in this cohort of underserved
older adultswithdiabetes.TheIDEATeltelemedicine intervention wasassociatedwith improve-
ment in glycemic control, particularly in Hispanics, who had the highest baseline A1C levels,
suggestingthattelemedicinehasthepotentialtohelpreducedisparitiesindiabetesmanagement.
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T
he prevalence of diabetes is highest
in older adults and higher in His-
panics and non-Hispanic blacks
(blacks) than in non-Hispanic whites
(whites) (1,2). A greater proportion of
whites achieve good glycemic control
(A1C ,7.0%) than blacks or Hispanics
(2,3). The development of diabetes-
relatedcomplicationsisrelatedtoglycemic
control (4). Poor access to care, particu-
larly forunderservedpopulations,isabar-
rier to improving outcomes. Telemedicine
has the potential to help overcome this
barrier.
The Informatics for Diabetes Edu-
cation and Telemedicine (IDEATel)
project, a large, randomized trial that ex-
amined the effectiveness of telemedicine
in diabetes management,is unique in that
it followed, for 5 years, ethnically diverse
older adults (n = 1,665) living in under-
served areas(5–7). This target population
was chosen because it was considered to
havethegreatestneedforinterventionus-
ing telemedicine. Intention-to-treat mod-
els showed that the telemedicine group
compared with usual care had lower
A1C levels (P = 0.001); mean 6 SE A1C
levels (adjusted for clustering and hetero-
geneous variances) in usual care versus
intervention groups were 7.45 6 0.06
and 7.43 6 0.05% at baseline and
7.38 6 0.06 and 7.09 6 0.06% after 5
years (7). In this article, we examine fac-
tors associated with improvement in A1C
and the relative effectiveness of the inter-
vention in the context of decreasing
health disparities among ethnically di-
verse groups.
RESEARCH DESIGN AND
METHODS—Participants (n = 1,665)
were Medicare beneﬁciaries with diabetes
living in federally designated Medically
Underserved or Health Professional
Shortage Areas, ﬂuent in English or Span-
ish, who provided informed consent. Ex-
clusions included moderate or severe
cognitive impairment and severe comor-
bid conditions (5). Participants in the
usual care (n = 821) and telemedicine in-
tervention (n = 844) groups were similar
at baseline in race/ethnicity (~50% white,
15% black, 35% Hispanic), age at ran-
domization (mean 71 years), BMI (mean
32 kg/m
2), sex(63% female), married/living
with signiﬁcant other (41%), education (10
years), and duration of diabetes (11 years).
Recruitment details (Consolidated Stand-
ardsofReportingTrials[CONSORT]State-
ment) have been published (7).
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ORIGINAL ARTICLEStudy design
Subjects were randomized within pri-
mary care provider (PCP) practices to
the telemedicine group or usual care
between 2000 and 2002, with participa-
tion from 2000 to 2007 (5). Telemedicine
subjects received a home telemedicine unit
to videoconference with a diabetes educa-
tor every 4–6 weeks for self-management
education, review of transmitted home
blood glucose and blood pressure mea-
surements, individualized goal-setting,
and access to educational web pages cre-
atedbytheAmericanDiabetesAssociation
in English and Spanish (5–8). The target
A1C was #7.0% except for participants
with signiﬁcant reduced life expectancy
and/or severe hypoglycemicunawareness,
for whom the target was #8.0%. The
intervention used bilingual educators at
Columbia University in New York City
(urban subjects) and educators atthe State
University of New York (SUNY) Upstate
Medical University in Syracuse (rural sub-
jects).Diabeteseducators,supervisedbyan
endocrinologist, made recommendations
to PCPs for therapy changes.
Measures
Participants had annual assessments by per-
sonnelblindedtointerventionstatus.Assess-
ments included A1C (primary outcome),
BMI, urine microalbumin-to-creatinine
ratio, and completion of the SHORT-
Comprehensive Assessment and Referral
Evaluationdepressionscale(9,10),Charlson
Comorbidity Index (11), Lubben Social
Networkscale(12),andgeneralhealthshort
form (SF-12). A1C levels were performed
by the Medstar Laboratory (Washington,
DC) using boronate afﬁnity chromatogra-
phy (Primus CLC 385).
Analyses
A1C levels were ﬁrst analyzed for each
racial/ethnic group using the model pre-
viously described (7). Nonlinear models
with quadratic [group 3 (time)
2] (time-
centered) and/or exponential (e
2time)
terms to model nonlinearity with a ﬁrst-
order auto-regressive covariance struc-
ture was used for this analyses (SAS Proc
Mixed), adjusted for clustering and het-
erogeneous variances. A1C was also pre-
dicted with the ethnic/racial groups
entered as covariates along with number
of glucose uploads, female sex, insulin
use, oral hypoglycemic agent (OHA)
use, education, dual Medicare/Medicaid
eligibility, and BMI. The number of glu-
cose uploads, insulin use, OHA use, and
BMIweretreatedastime-varyingcovariates.
Whites were used as the reference group
for ethnicity. Usual care participants were
assigned a value of zero for number of glu-
cose uploads.
For intervention group participants,
the number of glucose uploads was com-
putedusingthemidpointbetweenannual
assessment dates. “Baseline” refers to the
ﬁrst 6 months of participant enrollment
and “year 1” refers to the 6 months before
and the six months after the participants’
year1visitdate.SASProcMixedwasused
topredictnumberofglucose uploads,ad-
justing for clustering within PCP. A com-
pound symmetry covariance structure
was used. Log time [log(time + 0.01)]
was included to model the rapid increase
in the number of glucose uploads. Only
telemedicine intervention group partici-
pants were included in the analyses of
glucose uploads (n = 844).
RESULTS—Baseline characteristics by
race/ethnicity are shown in Table 1. A
higher proportion of whites were male
and married/living with a signiﬁcant other;
this group was older, more highly edu-
cated,andhadhigherBMIlevelsandlower
A1C levels than the other racial/ethnic
groups. Hispanics had the lowest levels of
education, income, and BMI; had higher
Medicaid eligibility; and were least likely
to report knowing how to use a computer.
Charlson Comorbidity Index scores did
notdifferbetweentheracial/ethnicgroups,
butthereweresigniﬁcantdifferencesinde-
pression and general health.
A1C levels over time (adjusted means
and SE) in each racial/ethnic group are
showninTable2(seealsoSupplementary
Table 1, observed means [SD]). At base-
line, whites had mean A1C levels of 6.97
and 7.10% in usual care and telemedicine
groups, respectively, and A1C levels
,7.0% over years 1–5i nb o t hg r o u p s .
Blacks had worse glycemic control (A1C
.7%) in both the telemedicine and usual
care groups at baseline, with the telemed-
icine group trending toward better con-
trol over time, achieving mean A1C
,7.0%at5years.Hispanicshadthehigh-
estA1Clevelsatbaseline(7.94and7.69%
in usualcare and telemedicine groups, re-
spectively).WhereasA1Clevelsremained
.7.0%, the Hispanic telemedicine group
compared with the usual care group had
signiﬁcantly lower A1C levels (7.32 vs.
7.82%)attheendof5years.Thetreatment
effectwas0.50(95%CI0.22–0.78)forHis-
panics compared with 0.29 (0.12–0.46)
overall, as previously reported (6). A1C
levels fell in all three ethnic/racial groups
(Tables 2 and 3). IDEATel was powered
to detect a change in the total sample (n =
1,665). As previously reported, there
w a sar e d u c t i o ni nA 1 Ci nt h et r e a t m e n t
comparedwiththeusualcaregroupover-
all(7).Becauseoftherelativelylargereduc-
tion in the Hispanic subgroup (Fig. 1), the
difference between treatment and usual
care groups was statistically signiﬁcant in
this subgroup. There was a signiﬁcant dif-
ference in the slopes between the treat-
ment groups for blacks (group by time
2
P = 0.0264) and Hispanics (group by
time
2 P = 0.0317; group by exponen-
tial time P = 0.0250), but not for whites
(P = 0.9269).
Observed A1C levels [mean (SD)] by
sex over 5 years are shown (Supplementary
Table 2). For females, A1C was 7.40%
and 7.35% at baseline, and 7.33% and
7.01% at 5 years in usual care and tele-
medicine groups. For males, A1C was
7.40% at baseline in both groups, and
7.31% and 7.15% at year 5 in usual care
and telemedicine groups. Insulin use
over the 5 years was also examined
(SupplementaryTable3).Forindividuals
with A1C $7.0%, the proportion who
used insulin at baseline and year 5 was
34 and 48% in whites, 35 and 47% in
blacks, and 33 and 43% in Hispanics.
For individuals with A1C ,7.0%, the
proportion who used insulin at baseline
and year 5 was 18 and 25% in whites, 25
and 30% in blacks, and 16 and 17% in
Hispanics.
A1C levels were analyzed with racial/
ethnic groups entered as covariates along
with number of glucose uploads (Fig. 2),
female sex, insulin use, OHA use and
BMI; number of glucose uploads, insulin
use, OHA use and BMI were treated as
time-varying covariates. These analyses
showed that being female (P = 0.003),
having more glucose uploads (P =
0.016) and taking OHAs (P = 0.004)
were associated with lower A1C levels;
taking insulin was associated with higher
A1C levels (P , 0.0001) Blacks and His-
panics had higher mean A1C levels (P ,
0.0001) compared with whites (Table 3).
BMI was not signiﬁcantly associated with
A1C levels. Blacks and Hispanics had sig-
niﬁcantly fewer glucose uploads than
whites (P , 0.0001; Supplementary
Table 4).
At baseline, approximately half of
participants had diabetes for $10 years,
with no signiﬁcant differences between
racial/ethnic groups (Table 1). Similar
proportions of participants in each ra-
cial/ethic group at baseline were using
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and insulin therapy. Over time, insulin
use increased in all racial/ethnic groups
for participants with A1C levels .7.0%
(Supplementary Table 3); participants
taking insulin had higher A1C levels
over time (P , 0.0001).
CONCLUSIONS—These analyses
demonstrated racial/ethnic disparities in
glycemic control at baseline among
IDEATel participants, who were older,
ethnically diverse, and living in under-
served areas. Duration of diabetes did not
differ between racial/ethnic groups. There
may have been earlier detection, more
intensive care, or less advanced disease
before the baseline visit in whites, but
comorbidities were similar among the
racial/ethnic groups.Disparitiesinglycemic
control have been previously reported,
with Hispanics having worse control
despite quality improvement efforts
(13,14).
We report a persistent beneﬁto ft e l e -
medicine, particularly in Hispanics, the
group with the worst glycemic control
and the lowest income, educational at-
tainment, and computer experience.
There was high participant and PCP
satisfaction (15,16). Although Hispanics
had the greatest reduction in A1C in re-
sponse to the intervention, their average
Table 1—Baseline characteristics by racial/ethnic group (% unless otherwise indicated)
Race/ethnicity
White Black Hispanic P
n 821 248 585
Age (years)* 71.28 6 6.95 70.73 6 7.06 70.27 6 5.88 ,0.05
Female sex 55.54 74.60 68.38 ,0.01
Education (years)* 11.99 6 2.86 10.49 6 2.93 6.33 6 3.74 ,0.01
Marital status Married/living with signiﬁcant other 56.39 16.13 30.26 ,0.01
Single, never married 4.26 23.39 16.41
Separated/divorced 10.48 18.95 26.15
Widowed 28.75 41.13 27.18
Data missing 0.12 0.40 0.00
Lives alone Yes 31.67 50.20 40.58 ,0.01
Annual household income
(dollars) ,5,000 2.92 3.23 5.30 ,0.01
5,001–10,000 14.01 56.85 85.47
10,001–20,000 33.25 25.40 6.67
20,001–30,000 21.92 3.23 0.17
30,001–40,000 8.16 0.00 0.00
.40,000 10.35 1.21 0.17
Data missing 9.38 10.08 2.22
Participant dually eligible for
Medicare and Medicaid (yes) 12.30 43.15 74.70 ,0.01
Duration of diabetes (years) ,5 32.28 25.40 29.74 NS
5–9 20.58 21.77 18.97
10–14 15.96 13.71 19.49
$15 29.72 37.50 31.28
Data missing 1.46 1.61 0.51
Diabetes treatment Oral agents alone (monotherapy) 36.66 39.52 36.24 NS
Oral combination therapy
(2 or more classes) 30.69 24.60 30.77
Insulin alone 11.08 18.15 9.91
Insulin and pills 14.49 10.89 16.07
Diet alone 7.06 6.45 6.84
Data missing 0.00 0.40 0.17
Participant knows how to use a
computer No 63.95 88.71 96.75 ,0.01
Yes 34.59 10.08 2.91
Data missing 1.46 1.21 0.34
BMI (kg/m
2)* 33.11 6 7.02 32.91 6 7.38 29.77 6 5.47 ,0.01
A1C (%)* 7.02 6 1.25 7.58 6 1.78 7.79 6 1.68 ,0.01
Urine microalbumin-to-creatinine ratio
(log transformed)* 1.56 6 0.53 1.47 6 0.58 1.54 6 0.57 NS
Charlson Comorbidity Index* 2.89 6 2.04 2.82 6 1.79 2.91 6 1.71 NS
CARE Depression* 4.47 6 3.69 5.26 6 4.14 7.54 6 5.73 ,0.01
Index of General Health* 3.44 6 1.70 4.06 6 1.88 4.85 6 1.71 ,0.01
*Data are means 6 SD. Charlson, Depression, and General Health are all measured in the disordered impaired direction.
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Telemedicine, A1C, and health disparitiesA1C was higher than in whites or blacks.
It is possible that this group is more dis-
trustful of taking medications, has difﬁ-
culty with numeracy, and is less likely to
followPCPadvice,ortheirPCPswereless
aggressive in prescribing medications
(17–19). The Hispanics had the greatest
dual eligibility for Medicare and Medic-
aid, so cost of medications should have
been less of a problem compared with
theother groups.Wepreviouslyreported
that although IDEATel telemedicine par-
ticipants used more statin therapy than
usual care, Hispanics were less likely to
take statins, suggesting a possible reluc-
tance to take medications (20). Blacks
were reported to have higher A1C levels
at similar levels of glycemia (21). Given
the small difference in A1C levels between
whites and blacks at 5 years, it is possible
that the intervention eliminated disparities
in glycemia between these two groups.
In the intervention, educators used
home televisits every 4–6w e e k sw i t h
goal-setting to encouragelifestyle change.
The most common goals were related to
monitoring (8). Glucose uploads were re-
viewed at each televisit. More uploads
wererelatedtolowerA1Cvalues,perhaps
reﬂecting improved adherence and suc-
cess with goal-setting. Glucose upload
levelswerehigheramongwhites,suggest-
inglessself-monitoringamongblacksand
Hispanics.
The telemedicine intervention was
shown to have been related to improved
self-efﬁcacy, which was directly and in-
directly related to improved glycemic
control (22). The intervention also im-
proved self-reported diet and exercise
knowledge, practices, and behaviors
(23). Hispanics were less obese than
blacks and whites, but BMI was not asso-
ciatedwithlowerA1Clevels.Thepropor-
tion of females in the Hispanic group was
intermediate compared with blacks and
whites. Female sex was also associated
with lower A1C levels. The reason for
this is unclear; we cannot determine
from this study if females respond better
to this intervention than males. There
were differences in depression scores at
baselinebetweentheracial/ethnicgroups.
Because we have previously shown that
baseline depression did not predict
change in A1C for usual care or telemedi-
cine intervention groups in any racial/
ethnic group at 1 year (24), we think it
is unlikely that depression played a major
role in this difference. The number ofgly-
cemic control medications used did not
signiﬁcantly differ in usual care or tele-
medicine groups at baseline or over time.
Asexpected,moreinsulinwasusedinpar-
ticipants with A1C levels .7.0%.
Home televisits to improve glycemic
control were part of a larger telemedicine
intervention that was designed to im-
prove comprehensive diabetes manage-
ment including blood pressure and lipid
levels (5–7). Reduction in Medicare
Table 3—Predictors of A1C levels
Estimate SE P
Intercept 6.8949 0.1631 ,0.0001
Group 20.0911 0.0630 0.1486
Time 0.0727 0.0187 0.0001
Group by time
2 20.0380 0.0156 0.0148
Exponential time 0.5194 0.0784 ,0.0001
Group by exponential time 0.4312 0.1449 0.0029
Number of glucose uploads 20.0002 0.0001 0.0163
Black 0.4074 0.0815 ,0.0001
Hispanic 0.7251 0.0845 ,0.0001
Female 20.1524 0.0509 0.0028
Takes insulin 0.3537 0.0432 ,0.0001
BMI 20.0029 0.0032 0.3706
Education (years) 0.0076 0.0074 0.3039
Dual eligibility 0.0296 0.0617 0.6309
Takes oral glycemic medications 20.1232 0.0426 0.0038
Fit statistics
22 Residual log likelihood 20,926.5
Akaike’s information criterion (AIC) 20,936.5
Corrected Akaike’s information criterion (AICC) 20,936.6
Bayesian information criterion corrected
Akaike’s information criterion (BIC) 20,957.7
Nonlinear models with quadratic [group 3 (time)
2] (time-centered) and/or exponential (e
2time)t e r m st o
model nonlinearity with First Order Auto-Regressive covariance structure were used (SAS Proc Mixed).
Model was adjusted for clustering and heterogeneous variances. Up to six waves of data (baseline plus ﬁve
follow-ups) were included. Number of glucose uploads, diabetes medication status, and BMI were treated as time-
varying covariates. For number of glucose uploads, usual care participants and telemedicine intervention partic-
ipants with no uploads were assigned zero. Non-Hispanic white is the reference group for race/ethnicity.
Table 2—Adjusted mean and SE A1C levels (%) by racial/ethnic group
White Black Hispanic
Usual care Telemedicine Usual care Telemedicine Usual care Telemedicine
Mean SE Mean SE Mean SE Mean SE Mean SE Mean SE
Baseline 6.97 0.06 7.10 0.06 7.56 0.14 7.61 0.12 7.94 0.09 7.69 0.08
Year 1 6.82 0.05 6.82 0.05 7.17 0.13 7.21 0.11 7.60 0.08 7.27 0.08
Year 2 6.81 0.05 6.76 0.06 7.08 0.13 7.23 0.12 7.54 0.08 7.27 0.08
Year 3 6.84 0.05 6.77 0.06 7.09 0.13 7.26 0.13 7.61 0.09 7.35 0.09
Year 4 6.88 0.06 6.82 0.06 7.14 0.14 7.19 0.12 7.71 0.08 7.37 0.08
Year 5 6.93 0.07 6.87 0.09 7.20 0.16 6.95 0.16 7.82 0.10 7.32 0.10
Nonlinear models with quadratic [group 3 (time)
2] (time-centered) and/or exponential (e
2time) terms to model nonlinearity with First Order Auto-Regressive
covariance structure were used for this analysis (SAS Proc Mixed). Model was adjusted for clustering and heterogeneous variances. Up to six waves of data (baseline
plus ﬁve follow-ups) were included in the analyses.
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ulation was not observed (25). Imple-
mentation costs were high, representing
thehardwareandsoftwareavailablewhen
IDEATel was initiated. Lower cost tech-
nology is needed.
Strengths of IDEATel include that it
was a large 5-year randomized trial that
successfully used home telemedicine in
an underserved ethnically diverse older
population with diabetes. Limitations are
acknowledged. Because all racial/ethnic
groups did not have similarly elevated
A1C levels at baseline, we do not know if
they all would have responded similarly
to the telemedicine intervention, al-
though blacks responded in a fashion
more similar to white participants. There
were relatively few participants with A1C
levels (.9%), so there was insufﬁcient
power to examine the effectiveness of
this intervention in individuals with the
worst glycemic control. Because glucose
levels were uploaded at each televisit, we
could not distinguish between the effects
of goal-setting, review of uploads, and
other aspects of the intervention. Exami-
nationoftheroleofrace/ethnicitywasnot
the primary preplanned analysis, and the
study was not originally powered to con-
sider such subgroup analyses. Lastly, we
were unable to assess intensiﬁcation of
dosing of medications, including insulin.
In conclusion, we demonstrate, for
the ﬁrst time, that a telemedicine inter-
vention that includes regularly scheduled
home televisits with a diabetes educator,
review of glucose uploads, individualized
goal-setting, web access to educational
materials, and recommendations for
changes in therapy to PCPs can reduce
Figure 1—A1C levels (adjusted means) by racial/ethnic group. A:W h i t e .B: Black. C: Hispanic. Error bars represent 95% CIs.
Figure 2—Number of glucose uploads (adjusted means) by racial/ethnic group in telemedicine
intervention participants (n = 844). Error bars represent 95% CIs.
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Telemedicine, A1C, and health disparitiesracial/ethnic disparities in glycemic con-
trol in older underserved adults. Hispan-
ics had the highest A1C levels at baseline
and demonstrated the greatest improve-
ment. Whereas reduction in health dispar-
ities is difﬁcult to achieve, these ﬁndings
add to our knowledge about factors that
may contribute to the inability to achieve
glycemic goals. Blacks and Hispanics, the
groups with lower education attainment,
were less likely to monitor their blood
glucose levels than whites, and such mon-
itoring was related to better glucose con-
trol. Further studies including tailored
education interventions for underserved
diabetic populations are warranted.
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